Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.
about
Human papillomavirus-associated cancers: A growing global problemRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerMate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral EtiologyGenomic landscape of human papillomavirus-associated cancersPredictive value of epigenetic alterations in head and neck squamous cell carcinomaDiagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.International Federation of Head Neck Oncology Society 5(th) World Congress/American Head Neck Society 2014 updateThe head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesLong-term quality of life after transoral laser microsurgery for laryngeal carcinoma.Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomasSaliva Liquid Biopsy for Point-of-Care Applications.A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.Should We De-escalate the Treatment for HPV-Positive Tumors?Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirus.Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.Toll-like receptor 5 and 7 expression may impact prognosis of HPV-positive oropharyngeal squamous cell carcinoma patients.Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma.[The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery].Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis.HPV-Associated Head and Neck Cancer.Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.Prognostic significance of decreased expression of six large common fragile site genes in oropharyngeal squamous cell carcinomas.Beware of the dangers along the path towards the diagnosis of HPV-driven oropharyngeal squamous cell carcinoma.Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer.Staging Neck Dissection and Transoral Robotic Surgery Treatment Algorithm in Palatine Tonsil Cancer.Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma.Human Papillomavirus-Related Cancers.Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification.
P2860
Q26748962-54465CE9-C8B1-4CA8-9735-18A6748E67ECQ26782255-2EE43285-B4B7-4497-A0BF-3CCE024CAEA6Q26799320-E446382F-4119-45FA-9B5E-1F837C4CEA00Q26997399-17C3169E-0E9B-42E9-B4EC-1349DA8A5A89Q27690755-73436521-4B9A-47C7-ADDD-3B87FF5EC82DQ30241076-909521B8-2AD7-4B08-B432-BBB34B0E3116Q30980315-32B2372B-D92C-4EE0-8C5A-3959D1F15D55Q33798848-E877D7D9-344D-4E77-BD26-31CD633DB411Q34368312-90A51A0A-F09C-4295-AEBE-9C0ACD55AF54Q34619156-F03E31CD-77EA-4AF3-AB22-B2AEFEA3B20BQ36154717-87A02B38-E3D5-4882-9DE7-6266B620EE7FQ36823719-17271B34-C9C1-49B7-96AC-C421AB4197FFQ36838932-AF96AAE1-5F4A-4E68-89B2-B724B7D74C67Q37094944-68E17489-C3E6-42C6-884E-A3E824F96CD9Q37747010-AC7D100C-83BB-494A-8DC5-83F897F33869Q38257116-35FC95D8-22C0-4AB2-A2A1-2CAB5D178FD2Q38599419-97EEA6C8-D8E3-4A6F-BD9A-FEEE421CB320Q38650589-1C621B84-698E-47D0-A7F7-5F884DC4EFECQ38653658-E1B2E39D-0AC0-4582-83E0-92F648504CC8Q38815058-753801CE-4F28-45D8-9308-E2D0429CDA1DQ39216252-DC1D633C-BA65-4234-9C64-3FA6CC49BAE7Q39626142-453D9FE0-03D7-4557-85BC-8812D10F5FC3Q40063898-1B18F46F-E79A-4E38-A652-12901B68156FQ40070631-D130EFF1-181B-45B2-AB8E-13C06DCF0C00Q40130721-2FC8E398-E212-4A26-AB8E-07D830A64543Q40214883-42525C5B-D842-4367-8566-D625AFCDAFE3Q40224459-E9727237-6B6A-4519-93EA-23A8BDE0C596Q40765189-15878C02-A84C-4DD0-A1DF-E8078212864AQ40778155-C01F650E-487E-4275-B3B5-1718DE332A66Q40875373-04B48D6F-D448-45CB-8E03-7CB116E812D5Q41667158-7B9B61F1-788A-4A30-8CC4-3A1CC18CDBDAQ41852350-B61FA9E9-04E8-4036-BF25-D1D54AF51031Q42292536-AC1C2488-A6BC-4011-8295-156621695A86Q42700937-646C8A6E-21C2-4459-8B83-9FED5FC68637Q46053548-B64D3CD0-9BE9-4553-A8FD-F9563C7D5899Q47381216-D0BEC62F-F9B2-440B-ADCF-7A703AE6E682Q47606362-37E637E9-80D3-4289-AADB-D27F81A3567EQ47609106-26BAF10A-64B9-485C-A6B6-837B436F85E5Q47679508-480A840D-E043-4786-A36C-B00FC2BB14C4Q49364421-262453D3-4526-449F-BE9D-A816FF5A8E6D
P2860
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment de-escalation in HPV ...... tical issues and perspectives.
@en
type
label
Treatment de-escalation in HPV ...... tical issues and perspectives.
@en
prefLabel
Treatment de-escalation in HPV ...... tical issues and perspectives.
@en
P2093
P2860
P356
P1476
Treatment de-escalation in HPV ...... tical issues and perspectives.
@en
P2093
H Mirghani
J Lacau St Guily
P Blanchard
P2860
P304
P356
10.1002/IJC.28847
P577
2014-04-04T00:00:00Z